Intragastric volume-occupying device and method for fabricating same
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61M-029/00
A61F-005/00
A61M-031/00
A61B-017/12
A61B-019/00
A61M-025/10
출원번호
US-0580044
(2009-10-15)
등록번호
US-9072583
(2015-07-07)
발명자
/ 주소
Brister, Mark C.
Patel, Kaushik A.
Rasdal, Andrew P.
Quintana, Nelson
Drake, Neil R.
Llevares, Antonio C.
Markovic, Dubravka
VandenBerg, Amy D. L.
출원인 / 주소
Obalon Therapeutics, Inc.
대리인 / 주소
Knobbe Martens Olson & Bear, LLP
인용정보
피인용 횟수 :
0인용 특허 :
52
초록▼
Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in
Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.
대표청구항▼
1. An intragastric balloon system comprising a volume occupying subcomponent and a deflation subcomponent, wherein the deflation subcomponent is configured to deflate the intragastric balloon system after a preselected period of time has lapsed since deployment of the system in vivo, wherein the def
1. An intragastric balloon system comprising a volume occupying subcomponent and a deflation subcomponent, wherein the deflation subcomponent is configured to deflate the intragastric balloon system after a preselected period of time has lapsed since deployment of the system in vivo, wherein the deflation subcomponent comprises a biodegradable or dissolvable head that is configured to, upon degradation, allow fluid to escape from the volume-occupying subcomponent, wherein a first portion of the head is configured to degrade faster than a second portion of the head, wherein the first portion of the head is configured to stabilize the second portion of the head such that, in vivo, when the first portion of the head degrades, the second portion of the head destabilizes and is released from the head, thereby accelerating a process of deflation of the volume occupying subcomponent, wherein the volume occupying subcomponent comprises a composite wall configured to maintain a CO2 leak rate of less than or equal to 40 cc/m2/day at 37° C., wherein the composite wall comprises multiple layers of materials, the multiple layers of materials including: a polyethylene outer supporting layer having a Young's Modulus of 500 Mpa or greater and configured to be proximal to the gastric environment or the central lumen of the balloon;an ethylene vinyl alcohol inner CO2 barrier layer configured to not be directly exposed to the gastric environment or a central lumen of the balloon, such that its CO2 barrier properties are not substantially affected by exposure to humidity levels within the gastric environment or within a central lumen of the balloon;a nylon inner CO2 barrier layer configured to not be directly exposed to the gastric environment or a central lumen of the balloon, such that its CO2 barrier properties are not substantially affected by mechanical forces during processing, compacting, or application of external gastric pressures; andan outer layer on an opposite side of the composite wall from the polyethylene outer supporting layer,wherein the intragastric balloon system is configured to retain more than 75% of an original nominal volume in the gastric environment for at least 25 days. 2. The intragastric balloon system of claim 1, wherein the ethylene vinyl alcohol inner CO2 barrier layer has a thickness of at least about 2 microns. 3. The intragastric balloon system of claim 1, wherein the ethylene vinyl alcohol inner CO2 barrier layer is situated between two polyethylene layers, and wherein the ethylene vinyl alcohol inner CO2 barrier layer and the two polyethylene layers are bonded together with tie layers. 4. The intragastric balloon system of claim 1, wherein the intragastric balloon system is configured to be swallowable, the system further comprising a self-sealing valve system attached to the composite wall of the balloon in a central lumen of the balloon by an adhesive with a shear force greater than about 40 N, the self-sealing valve system comprising a septum, a retaining structure, and a continuous ring, wherein the septum has a durometer that is less than a durometer of the retaining structure, wherein the continuous ring is configured to exert a compressive force on the septum, wherein the balloon has a weight of less than about 15 g, wherein the balloon is configured to have a shape upon full inflation selected from the group consisting of ellipsoid, spheroid, and oblate spheroid, and wherein the balloon is configured to have a volume of from about 90 cm3 to about 350 cm3 upon full inflation. 5. The intragastric balloon system of claim 1, wherein the head comprises an outer portion held together by a faster degrading centerpiece. 6. The intragastric balloon system of claim 1, wherein the head comprises a slower degrading outer half and faster degrading inner half. 7. The intragastric balloon system of claim 1, wherein the head comprises an inner portion partially held together by a water soluble adhesive configured to, in vivo and upon degradation of the outer half of the head, come in contact with contents of the stomach, resulting in accelerated disintegration of the inner portion of the head. 8. The intragastric balloon system of claim 1, comprising a plurality of heads. 9. The intragastric balloon system of claim 1, wherein the head contains materials configured to be degraded by enzymes that are normally present in a stomach. 10. The intragastric balloon system of claim 9, wherein the head contains materials configured to be degraded by pepsin or other proteases. 11. The intragastric balloon system of claim 1, wherein the head incorporates a tension element. 12. The intragastric balloon system of claim 11, wherein the tension element is selected from the group consisting of a spring, a degradable link, and one or more plugs. 13. The intragastric balloon system of claim 1, wherein the deflation subcomponent comprises a material configured to degrade upon contact with a substance ingested by a patient. 14. The intragastric balloon system of claim 13, wherein the material forms a portion of the volume-occupying subcomponent or a sealing element incorporated within the volume-occupying subcomponent. 15. The intragastric balloon system of claim 14, wherein the material is a polymer that is degraded by one or more preselected enzymes or bacteria, wherein the substance is the one or more preselected enzymes or bacteria. 16. The intragastric balloon system of claim 1, wherein the volume-occupying subcomponent incorporates an elastomeric material that forms a sheath or wall configured to apply a contracting force on the volume-occupying subcomponent and facilitate deflation once the volume-occupying subcomponent has been breached. 17. The intragastric balloon system of claim 16, wherein the contracting force applied by sheath or wall is applied primarily along a longitudinal axis such that the deflated volume-occupying subcomponent has a first dimension that is greater than a second dimension. 18. The intragastric balloon system of claim 1, wherein the deflation component comprises a duct valve or other type of valve configured to allow fluid to exit the volume-occupying subcomponent upon initiation of deflation but that permits little or no fluid to enter or flow back into the volume-occupying subcomponent. 19. An intragastric balloon system comprising a volume occupying subcomponent and a deflation subcomponent, wherein the deflation subcomponent is configured to deflate the intragastric balloon system after a preselected period of time has lapsed since deployment of the system in vivo, wherein the deflation subcomponent comprises a biodegradable or dissolvable head that is configured to, upon degradation, allow fluid to escape from the volume-occupying subcomponent, wherein a first portion of the head is configured to degrade faster than a second portion of the head, wherein the head incorporates a tension element comprising a plug, wherein a degradable link is configured to secure the tension element around the plug such that, upon degradation of the degradable link, the tension element releases all or part of the plug from the head, thereby allowing for the escape of fluid from the volume-occupying subcomponent, wherein the volume occupying subcomponent comprises a composite wall configured to maintain a CO2 leak rate of less than or equal to 40 cc/m2/day at 37° C., wherein the composite wall comprises multiple layers of materials, the multiple layers of materials including: a polyethylene outer supporting Young's Modulus of 500 Mpa or greater and configured to be proximal to the gastric environment or the central lumen of the balloon;an ethylene vinyl alcohol inner CO2 barrier layer configured to not be directly exposed to the gastric environment or a central lumen of the balloon, such that its CO2 barrier properties are not substantially affected by exposure to humidity levels within the gastric environment or within a central lumen of the balloon;a nylon inner CO2 barrier layer configured to not be directly exposed to the gastric environment or a central lumen of the balloon, such that its CO2 barrier properties are not substantially affected by mechanical forces during processing, compacting, or application of external gastric pressures; andan outer layer on an opposite side of the composite wall from the polyethylene outer supporting layer,wherein the intragastric balloon system is configured to retain more than 75% of an original nominal volume in the gastric environment for at least 25 days.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (52)
Kullas Karen E. (Taunton MA) Giusto Joseph (Warren RI), Anti-obesity balloon placement system.
Imran, Mir; Herrmann, Peter; Syed, Baber; Williams, Timothy H.; Ong, Chang Jin; Method, Greg, Device, system and methods for the oral delivery of therapeutic compounds.
Matsuura, David G.; Gillespie, Walter D.; Wallin, Sheila K.; Connors, Kevin G.; Bullister, Edward, Devices and methods for attenuation of pressure waves in the body.
Lewkowicz,Shlomo; Gat,Daniel; Glukhovsky,Arkady; Khait,Semion; Iddan,Gavriel Joseph; Jacob,Harold; Swain,Christopher Paul, Floatable in vivo sensing device and method for use.
Yamamoto Taizo (Osaka JPX) Abe Kenji (Nara JPX) Matsuura Seinosuke (Souraku JPX), Hard capsule for pharmaceutical drugs and method for producing the same.
Weiner Brian C. (24 Bowling Green Pl. Staten Island NY 10314) Weiner Sarah H. (24 Bowling Green Pl. Staten Island NY 10314), Inflatable gastric device for treating obesity and method of using the same.
Gau Fred C. (14812 Imperial Dr. Libertyville IL 60048) Hancock John C. (449 Paseo del Descanso Santa Barbara CA 93105), Intragastric balloon with improved valve locating means.
Brister, Mark C.; Quintana, Nelson; Patel, Kaushik A.; Drake, Neil R.; Llevares, Antonio C.; Markovic, Dubravka; Rasdal, Andrew P.; VandenBerg, Amy D. L., Intragastric device.
Brister, Mark C.; Rasdal, Andrew P.; Drake, Neil R.; Lake, Matthew S.; Markovic, Dubravka; VandenBerg, Amy D. L.; Llevares, Antonio C.; Nider, Josefina, Intragastric device.
Berman Edward J. (3426 N. Meridian Indianapolis IN 46208) Rowe George A. (3426 N. Meridian Indianapolis IN 46208), Method and apparatus for reducing obesity.
Smith Jeffrey A. ; Wallace Daniel T. ; Hlavka Edwin J. ; Gresl Charles ; Lunsford John P. ; Chin Albert K., Method and inflatable chamber apparatus for separating layers of tissue.
Kim Sunyong (105 Valley Forge St. Charles MO 63303) Lee Dae W. (1575 N. Warson Rd. St. Louis MO 63132), Self-contained, self-inflating novelty balloon.
Imran, Mir, Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
Imran, Mir, Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.